Comments: NJ A2240 | 2022-2023 | Regular Session
Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Introduced - Dead) 2022-02-07 - Introduced, Referred to Assembly Health Committee [A2240 Detail]
Text: Latest bill text (Introduced) [HTML]
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Introduced - Dead) 2022-02-07 - Introduced, Referred to Assembly Health Committee [A2240 Detail]
Text: Latest bill text (Introduced) [HTML]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey A2240 at this time. |